The DEA stated its intention earlier this Summer to expand scientific and medical research into marijuana. As part of that process, the agency released details of the application process this week. According to a press release, “the total number of individuals registered by DEA to conduct research with marijuana, marijuana extracts, derivatives and delta-9-tetrahydrocannabinol (THC) has increased by more than 40 percent from 384 in January 2017 to 542 in January 2019. Similarly, in the last two years, DEA has more than doubled the production quota for marijuana each year based on increased usage projections for federally approved research projects.” Additional regulations will be created.
Read more here.